Professional
Added to YB: 2025-08-26
Pitch date: 2025-06-30
DHR [bullish]
Danaher Corporation
+16.22%
current return
Author Info
No bio for this author
Company Info
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.
Market Cap
$159.9B
Pitch Price
$196.64
Price Target
N/A
Dividend
0.57%
EV/EBITDA
22.21
P/E
46.51
EV/Sales
7.27
Sector
Life Sciences Tools and Services
Category
growth
Baron Durable Advantage Fund Added On Position: Danaher Corporation
DHR added to position: Leading life sciences supplier facing temporary sector pressure. 75% of bioprocessing business in Phase 3/commercial, less exposed to biotech funding constraints. Market leader in bioprocessing positioned to benefit from biosimilar wave after patent expirations. Minimal exposure to NIH funding cuts (low single-digit %).
Read full article (1 min)